SIGYN THERAPEUTICS, INC. Increase (Decrease) in Derivative Liabilities
SIGYN THERAPEUTICS, INC. (SIGY) reported Increase (Decrease) in Derivative Liabilities of $229.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2016-11-14
- SIGYN THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-09-30 was $2.69K.
- SIGYN THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-06-30 was $227.30K.
- SIGYN THERAPEUTICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-03-31 was -$988.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month |
|---|---|---|---|
| 2016-09-30 | $2.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $229.99K derived: sum of 2 quarters · filed 2016-11-14 | $229.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $227.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $226.31K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$988.00 10-Q · filed 2016-05-09 |